What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
Clinical Trial
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
Consumer Genetic Tests Accelerate Precision Medicine for Some Providers
Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific medications.
Like many such advances, availability of DTC tests is
Read More
COVID-19 Clinical Trials: How AI-Based Chatbots Can Provide Pandemic-Level Execution
More than 500 new COVID-19 related clinical trials have been registered as of the end of April. The race to find a COVID-19 vaccine is on and the public spotlight is on clinical trials. Strangely named drugs such as Hydroxychloroquine and Remdesivir have become household names and are featured and debated regularly on the 24-hour news channels.
The pressure to find a cure is intense. The locked-down world does not want to hear that at best, we may find a vaccine sometime in 2021. What
Read More
Sharecare Acquires Evidence-Based Behavior Change Apps MindSciences
What You Should Know:
- Sharecare announced the acquisition of Boston-based MindSciences, an evidence-based behavior change suite of apps focused on mental health (anxiety, stress management), smoking cessation, and weight loss/binge eating, and more.
- The acquisition rounds out Sharecare’s portfolio of mHealth-based therapeutic programs improving chronic disease risk and overall health outcomes by targeting varying aspects of well-being.
- Based on the work of Dr. Judson Brewer, now
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Inovalon Launches FHIR-Based Solution for Health Plan Compliance
What You Should Know:
- Inovalon announced the availability of its Cloud-Based “Consumer Health Gateway” Module, alleviating the need for health plans to build their own Patient Access API to comply with the new requirement of the 21st Century Cures Act.
- The Consumer Health Gateway is a consumer portal allowing the FHIR®-based exchange of a patient’s claims and clinical data securely with authorized third-party applications. It consists of a robust patient consent and authentication
Read More
Philips Launches HealthSuite Clinical Trial Accelerator
What You Should Know:
Philips launches HealthSuite Clinical Trial Accelerator
to help life science organizations run more flexible, patient-centric clinical
trials.
Clinical Trial Accelerator enables patient-centric trials
at home, managing the collection of data while providing the security and
compliance expected from both patients and life science organizations.
Philips, today
announced Clinical
Trial Accelerator on Philips HealthSuite. This new tailored set of
capabilities
Read More
Medable Lands $25M to Expand Platform for Decentralized Clinical Trials
What You Should Know:
- Medable raises $25M in funding to expand global platform for decentralized clinical trials led by GSR Ventures, with additional investment from existing investor PPD, Inc.
- Founded in 2015, Medable’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.
Medable, Inc., a Palo
Alto, CA-based global platform for
Read More
Stanford Medicine Awarded $2.5M Grant to Research Digital Health Tools for Hypertension
What You Should Know:
- American Heart Association awards Stanford Medicine a $2.5M grant for a digital health and clinical trial for treating hypertension in black and Hispanic participants and in drivers for ride-hailing companies.
- The award is part of a $14M grant to several institutions including Stanford School of Medicine, Cincinnati Children’s Hospital, Johns Hopkins University, and the University of Michigan for research on reducing healthcare disparities through digital health
Read More
